<?xml version="1.0" encoding="UTF-8"?>
<p id="par0280">Leronlimab is a humanized IgG4 monoclonal antibodies that blocks CC chemokine cellular receptor 5 (CCR5) and plays a key role in several immunological processes. Leronlimab is being evaluated for HIV and breast cancer treatment and it is believed to have an antiviral activity while mitigating the cytokine storm. Some claim that Leronlimab has achieved preliminary results in a few severe cases of COVID-19 [
 <xref rid="bib0415" ref-type="bibr">83</xref>,
 <xref rid="bib0420" ref-type="bibr">84</xref>].
</p>
